Mirror Biologics, Inc.
PrivateLast Round
Series A
Oct 11, 2022
Total Funding Raised
$30M
Company Overview
Mirror Biologics, Inc. is a biotechnology company that develops and manufactures off-the-shelf, living immune cell immunotherapies for the treatment of metastatic cancer and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mirror Biologics, Inc. Comparables
Compare Mirror Biologics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sana Biotechnology | 74% | |
| Artiva | 73% | |
| Atara Biotherapeutics | 73% | |
Mirror Biologics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 11, 2022 |
Key People
Founding team and executive leadership
Mirror Biologics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bradbury Asset Management (Hong Kong) Limited | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2024
Grew 16% QoQ, from 19 to 22 employees.
- Jul 9, 2024
Grew 18% QoQ, from 17 to 20 employees.
Mirror Biologics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mirror Biologics, Inc.'s valuation, stock price, and market status.